APA (7th ed.) Citation

S, D. M., P, B., S, B., R, D. V., EL, F., & GL, C. (2026). Cost-Effectiveness of Bivalent Prefusion F Vaccine for Prevention of Respiratory Syncytial Virus Among Older Adults in Italy. ClinicoEconomics and outcomes research : CEOR, 18, 584975. https://doi.org/10.2147/CEOR.S584975

Chicago Style (17th ed.) Citation

S, Di Matteo, Bonanni P, Boccalini S, Di Virgilio R, Fogliati EL, and Colombo GL. "Cost-Effectiveness of Bivalent Prefusion F Vaccine for Prevention of Respiratory Syncytial Virus Among Older Adults in Italy." ClinicoEconomics and Outcomes Research : CEOR 18 (2026): 584975. https://doi.org/10.2147/CEOR.S584975.

MLA (9th ed.) Citation

S, Di Matteo, et al. "Cost-Effectiveness of Bivalent Prefusion F Vaccine for Prevention of Respiratory Syncytial Virus Among Older Adults in Italy." ClinicoEconomics and Outcomes Research : CEOR, vol. 18, 2026, p. 584975, https://doi.org/10.2147/CEOR.S584975.